Thus, intellectual property rights
are designed to provide protection for the results of investment in the development of new technology giving the incentive and means to finance further research and development activities.
The appropriation of biological resources and knowledge through patents and intellectual property rights
without fair compensation is considered biopiracy, and the rosy periwinkle discoveries are frequently cited by the media and in nongovernmental organization literature as examples.
com's support for BSA's Model Business Practices on Intellectual Property Rights
, said Bob Kruger, vice president of enforcement for the Business Software Alliance.
China) presents 12 essays in which he explores various aspects of China's changing intellectual property rights
In fields ranging from software to biography, biotechnology to court reporting, the general tendency of intellectual property rights
has been to grasp outward, ever outward.
today strengthened its reputation as Telecom's most innovative market research and analyst firm launching the first and only available report on WiMAX/LTE 4G Intellectual Property Rights
, an exhaustive analysis of real-world IPR and patent data complemented by a comprehensive worldwide patent database.
While we have opted to out-license patent rights for both electrical and mechanical stimulation of the vagus nerve, we have retained our intellectual property rights
associated with the development of a small molecule drug that acts on the alpha-7 receptor.
National Instruments' Intellectual Property Rights
Vindicated Before U.
At the same time, the report to Congress highlights a number of areas of concern in areas such as intellectual property rights
, industrial policies, trading rights, transparency, and agriculture.
The DIRECTV Group, RAI and ESA, the holders of key DVB (Digital Video Broadcasting)-S2 intellectual property rights
, announced today the fundamental terms of a comprehensive licensing offering under their combined patent rights for DVB-S2 standardized technology.
Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has expanded and further strengthened the intellectual property portfolio for its serotonin platform by entering into an agreement to license certain intellectual property rights
from Ipsen (Euronext:IPN), an innovation driven international specialty pharmaceutical group.
Back to Basics respects the valid intellectual property rights
of others just as it expects others to respect Back to Basics' intellectual property rights